XML 43 R30.htm IDEA: XBRL DOCUMENT v3.25.3
Summary of Significant Accounting Policies (Details Narrative)
3 Months Ended 9 Months Ended
Sep. 30, 2025
USD ($)
shares
Sep. 30, 2024
USD ($)
Sep. 30, 2025
USD ($)
Segment
shares
Sep. 30, 2024
USD ($)
Dec. 31, 2024
USD ($)
Product Information [Line Items]          
Number of reportable segment | Segment     1    
Cash FDIC insurance $ 250,000   $ 250,000    
Cash SIPC insurance         $ 500,000
Legal and filing fees and costs $ 16,853 $ 45,416 $ 90,239 $ 192,239  
Pre funded warrants | shares 3,085,883   3,085,883    
Unexercised pre funded warrants | shares 659,772   659,772    
Foreign currency average rate 1.1692 1.0991 1.1182 1.0873  
Legal and filing fees and costs $ 1,750,658 $ 621,627 $ 3,080,302 $ 2,267,890  
Other costs and expenses $ 136,679 58,826 $ 282,764 316,551  
Related Party [Member]          
Product Information [Line Items]          
Legal and filing fees and costs   45,416   192,239  
Legal and filing fees and costs   283,053   907,069  
Other costs and expenses   $ 293,158   $ 1,168,582  
Cost of Sales [Member] | Revenue Benchmark [Member] | Product Concentration Risk [Member]          
Product Information [Line Items]          
Concentration risk percentage 10.00% 10.00%      
Research and Development Expense [Member] | Cost of Sales [Member] | Supplier Concentration Risk [Member] | Vendor And Consultant One [Member]          
Product Information [Line Items]          
Concentration risk percentage 21.40% 52.70% 24.30% 41.20%  
Research and Development Expense [Member] | Cost of Sales [Member] | Supplier Concentration Risk [Member] | Vendor And Consultant Two [Member]          
Product Information [Line Items]          
Concentration risk percentage 28.80% 21.10% 20.70% 30.40%  
Research and Development Expense [Member] | Cost of Sales [Member] | Supplier Concentration Risk [Member] | Vendor and Consultant Three [Member]          
Product Information [Line Items]          
Concentration risk percentage 14.20% 15.10% 18.90% 12.60%  
Research and Development Expense [Member] | Cost of Sales [Member] | Supplier Concentration Risk [Member] | Vendor and Consultant Four [Member]          
Product Information [Line Items]          
Concentration risk percentage     12.00%    
Research and Development Expense [Member] | Cost of Sales [Member] | Supplier Concentration Risk [Member] | Vendor and Consultant Five [Member]          
Product Information [Line Items]          
Concentration risk percentage     11.70%    
General and Administrative Expense [Member] | Cost of Sales [Member] | Supplier Concentration Risk [Member] | Other Vendor and Consultant [Member]          
Product Information [Line Items]          
Concentration risk percentage 1.00% 7.10% 2.90% 8.50%  
General And Administrative [Member] | Cost of Sales [Member] | Supplier Concentration Risk [Member] | Vendor And Consultant One [Member]          
Product Information [Line Items]          
Concentration risk percentage     10.00%    
General And Administrative [Member] | Cost of Sales [Member] | Supplier Concentration Risk [Member] | Vendor [Member]          
Product Information [Line Items]          
Concentration risk percentage 10.60% 18.40%      
General And Administrative [Member] | Cost of Sales [Member] | Supplier Concentration Risk [Member] | Stock Options Granted to Directors and Corporate Officers [Member]          
Product Information [Line Items]          
Concentration risk percentage 44.40% 12.80% 35.40% 12.60%  
General And Administrative [Member] | Cost of Sales [Member] | Supplier Concentration Risk [Member] | One Vendor and Consultant [Member]          
Product Information [Line Items]          
Concentration risk percentage       16.00%  
General And Administrative [Member] | Cost of Sales [Member] | Supplier Concentration Risk [Member] | Two Vendor And Consultant [Member]          
Product Information [Line Items]          
Concentration risk percentage       11.50%